Выбор редакции

Merck KGaA Seeks Rebif Extension - Analyst Blog

Merck KGaA recently filed a marketing application with the European Medicines Agency in its endeavor to expand the label of Rebif, its multiple sclerosis therapy.
НОВОСТИ ПО ТЕМЕ